CYP cynata therapeutics limited

7 yrs exclusivity in the US for CYP-001 to treat GvHD after FDA...

  1. 583 Posts.
    lightbulb Created with Sketch.  2
    7 yrs exclusivity in the US for CYP-001 to treat GvHD after FDA approval.
    Plus a heap of tax incentives and credits.

    Recruitment of second cohort progressing well.

    This is large.

    Is Sector (Sector Lead) still suspended? He must be doing very well out of this one.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.